MetLife Ranks 358th in Trading Volume as Shares Climb 1.42% Despite Earnings Shortfall and Regional Gains

On August 6, 2025, MetLife (MET) traded with a volume of $0.33 billion, ranking 358th in the market. Shares rose 1.42% despite a challenging earnings report. The insurer reported Q2 2025 adjusted earnings of $2.02 per share, missing the $2.16 consensus estimate, while revenue fell to $17.92 billion from the expected $18.72 billion. Key underperformers included the Group Benefits segment, which saw a 25% drop in adjusted earnings due to weaker underwriting in life and non-medical health products. Asia and Retirement & Income Solutions also faced declines, driven by lower investment and underwriting margins. Conversely, Latin America and EMEA posted gains, with EMEA up 30% on strong volume growth. CEO Michel Khalaf highlighted strategic progress in asset management and shareholder returns, including $900 million in buybacks and dividends.

The earnings shortfall stemmed from multiple factors, including reduced private equity returns, higher derivative losses linked to rising interest rates, and weaker underwriting margins. Despite a 5% growth in adjusted premiums and fees, net investment income fell in variable segments. The Group Benefits and Asia segments remained drag points, while MetLife’s book value per share increased 7% to $35.79. The company maintained its New Frontier strategy focus, emphasizing long-term resilience but acknowledged near-term challenges. Analysts now project Q3 2025 revenue at $18.87 billion and full-year revenue at $76.13 billion, reflecting cautious optimism amid mixed operational results.

The strategy of purchasing the top 500 stocks by daily trading volume and holding them for one day delivered a 166.71% return from 2022 to the present, outperforming the benchmark return of 29.18% by 137.53%. This underscores the role of liquidity concentration in short-term stock performance, particularly in volatile markets.